NASHVILLE--(BUSINESS WIRE)--Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced two oral presentations and one ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results